News
Medtronic paid CEO $9M in fiscal 2010
July 19, 2010 7:45 am | by MATTHEW PERRONE - AP Business Writer - Associated Press | CommentsMedtronic Inc., the world's largest medical device maker, paid Chief Executive William Hawkins $9 million in total compensation for fiscal 2010, roughly even with his earnings in the prior year, according to an analysis by the Associated Press.Hawkins, 56, took the reins of Medtronic in 2008,...
BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration
July 19, 2010 7:34 am | by Becton, Dickinson and Company | Comments(July 19, 2010) -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the creation of new dried reagents developed through a collaboration with ReaMetrix, a private biotechnology company based in Bangalore, India. The new reagent
World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients
July 19, 2010 6:38 am | by Bio-Medicine.Org | CommentsZURICH , July 19, 2010 /- Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.[1] Spanning 28 countries across 4...
Visage Imaging Releases Amira 5.3
July 19, 2010 6:35 am | by Bio-Medicine.Org | CommentsSAN DIEGO, Calif. , July 19 /- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D...
Adaptation in mole blood aids tunnelling
July 19, 2010 6:34 am | by EurekAlert | Comments(BioMed Central) "Super hemoglobin" allows moles to thrive underground. Researchers writing in the open-access journal BMC Evolutionary Biology have made the first identification of an adaptation in the blood of Eastern moles which allows more efficient transport of carbon dioxide,...
New biotech company grows from MCG diabetes and genomic research
July 19, 2010 6:34 am | by EurekAlert | Comments(Medical College of Georgia) A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer. Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and...
Slim- 30 Herb Supplement: Undeclared Drug Ingredient
July 19, 2010 6:30 am | by U.S. Food & Drug Administration | CommentsProduct found to contain undeclared N-Desmethyl Sibutramine and traces of Sibutramine.
MDMA (Ecstasy)-assisted psychotherapy relieves treatment-resistant PTSD
July 19, 2010 4:31 am | by EurekAlert | Comments(SAGE Publications UK) MDMA (also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE,...
Healthscope recommends Carlyle, TPG takeover bid
July 18, 2010 4:45 pm | by The Associated Press | CommentsHealthscope Ltd., Australia's second-largest private hospital operator, said Monday its board has unanimously recommended a 2 billion Australian dollar ($1.72 billion) takeover offer from U.S. private equity firms Carlyle Group and TPG Capital.Carlyle and TPG have offered AU$6.26 a share for...
Microbial world's use of metals mostly unmapped
July 18, 2010 12:34 pm | by Lawrence Berkeley National Laboratory | CommentsMicrobes boast a broader and more diverse array of metal-driven chemical processes than scientists imagined. In fact, most have yet to be discovered, according to a first-of-its-kind technique that catalogs all of the metals in a microbe. The method could lead to innovative clean energy...
Long-term care of HIV survivors needs additional research, attention
July 18, 2010 2:32 am | by Baylor College of Medicine | CommentsAs more effective treatments extend the lives of people with HIV, physicians need to research how best to provide care for these 'HIV survivors' as they age and acquire other chronic ailments, said experts at Baylor College of Medicine in a commentary that appears today in The Journal of...
HIV testing should be routine in cancer care
July 18, 2010 12:33 am | by Baylor College of Medicine | CommentsIn 2006, the U.S. Centers for Disease Control and Prevention recommended routine HIV testing in all healthcare settings as long as patients are given the opportunity to 'opt-out' or refuse the test. That recommendation is not widely followed, but it should be – especially in...
ArmaGen® Re-engineers Erythropoietin for Brain Penetration
July 16, 2010 5:35 pm | by Bio-Medicine.Org | CommentsLOS ANGELES , July 16 /- Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain...
FDA Consumer Health Information - Stolen Inhalers Pose Risk
July 16, 2010 5:34 pm | by Bio-Medicine.Org | CommentsSILVER SPRING, Md. , July 16 /PRNewswire-USNewswire/ -- The public should be on the lookout for stolen inhalers after some were found in a number of pharmacies. The Food and Drug Administration (FDA) says the safety and effectiveness of the stolen Advair Diskus inhalers cannot be assured,...
China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors
July 16, 2010 5:34 pm | by Bio-Medicine.Org | CommentsHARBIN, China , July 16 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...
